Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495339 | SCV000578373 | likely benign | Breast-ovarian cancer, familial 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000167277 | SCV000218120 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000429782 | SCV000526251 | likely benign | not specified | 2017-07-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000540388 | SCV000635784 | likely benign | Hereditary breast and ovarian cancer syndrome | 2017-10-21 | criteria provided, single submitter | clinical testing | |
Integrated Genetics/Laboratory Corporation of America | RCV000429782 | SCV000698837 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing |